Samsung Biologics
207940.KS
#478
Rank
โ‚น4.535 T
Marketcap
โ‚น93,493
Share price
-1.45%
Change (1 day)
25.91%
Change (1 year)

EPS for Samsung Biologics (207940.KS)

EPS in 2026 (TTM): โ‚น2,277

According to Samsung Biologics 's latest financial reports the company's current EPS (TTM) is โ‚น2,316. In 2025 the company made an earnings per share (EPS) of โ‚น1,716 an increase over its 2024 EPS that were of โ‚น961.25.

EPS history for Samsung Biologics from 2014 to 2026

Annual EPS

Year EPS Change
2026 (TTM)โ‚น2,27732.7%
2025โ‚น1,71678.53%
2024โ‚น961.2511.34%
2023โ‚น863.352.67%
2022โ‚น840.9283.43%
2021โ‚น458.4549.14%
2020โ‚น307.3926.39%
2019โ‚น243.21-12.58%
2018โ‚น278.22-320.64%
2017-โ‚น126.10-46.78%
2016-โ‚น236.95-105.09%
2015โ‚น4,657-1089.67%
2014-โ‚น470.58